PubRank

Tomohisa Tada

Author PubWeight™ 25.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials. Eur Heart J 2012 1.71
2 Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index. J Atheroscler Thromb 2015 1.60
3 Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease. Am J Cardiol 2013 1.56
4 Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 2013 1.19
5 Tissue characterization after drug-eluting stent implantation using optical coherence tomography. Arterioscler Thromb Vasc Biol 2013 0.95
6 Impact of CYP2C19 polymorphisms on the antiplatelet effect of clopidogrel in an actual clinical setting in Japan. Circ J 2009 0.94
7 Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2. Circ Cardiovasc Interv 2014 0.92
8 Uric acid and prognosis in angiography-proven coronary artery disease. Eur J Clin Invest 2012 0.90
9 Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol 2012 0.89
10 Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials. Clin Res Cardiol 2012 0.88
11 Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 2012 0.85
12 Clopidogrel resistance in Japanese patients scheduled for percutaneous coronary intervention. Circ J 2008 0.85
13 Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy. J Atheroscler Thromb 2012 0.81
14 Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2. Circ Cardiovasc Interv 2012 0.81
15 Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc Interv Ther 2011 0.80
16 Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison. Int J Cardiol 2013 0.80
17 Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials. EuroIntervention 2013 0.79
18 Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ J 2011 0.79
19 Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomised trials versus other limus-eluting stents and an adjusted indirect comparison. Heart 2012 0.78
20 Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention. Eur J Intern Med 2012 0.78
21 Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelor. Platelets 2012 0.78
22 Prediction of clopidogrel low responders by a rapid CYP2C19 activity test. J Atheroscler Thromb 2011 0.78
23 Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease. Clin Sci (Lond) 2013 0.78
24 Statin pretreatment and presentation patterns in patients with coronary artery disease. Cardiol J 2013 0.77
25 Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry. Cardiovasc Interv Ther 2012 0.77
26 Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation: a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Cardiovasc Interv Ther 2012 0.76
27 β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction. Cardiovasc Interv Ther 2012 0.76
28 Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease. Indian J Med Res 2014 0.75
29 Lost contact with vessel wall, signed contract with stent thrombosis? Eur Heart J 2012 0.75
30 Association of the use of proton pump inhibitors with adverse cardiovascular and bleeding outcomes after percutaneous coronary intervention in the Japanese real world clinical practice. Cardiovasc Interv Ther 2011 0.75
31 A case where the principle of "one question, one answer" may work better. Am Heart J 2012 0.75
32 QRS Score at Presentation Electrocardiogram Is Correlated With Infarct Size and Mortality in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. Circ J 2017 0.75
33 Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy. Am Heart J 2013 0.75
34 Time does not heal all wounds: very late stent thrombosis eight years after implantation of a sirolimus-eluting stent due to positive remodelling, saccular evaginations and marked vascular inflammation. EuroIntervention 2013 0.75